UK markets closed

Heart Test Laboratories, Inc. (HSCS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.33-0.09 (-1.66%)
As of 03:38PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.55M
Enterprise value -2.46M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)62.13
Price/book (mrq)0.41
Enterprise value/revenue 1.12k
Enterprise value/EBITDA -1.81

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-95.70%
S&P500 52-week change 327.84%
52-week high 3128.00
52-week low 35.21
50-day moving average 310.13
200-day moving average 326.61

Share statistics

Avg vol (3-month) 337.85k
Avg vol (10-day) 3128.98k
Shares outstanding 5655.62k
Implied shares outstanding 6655.62k
Float 8562.01k
% held by insiders 116.01%
% held by institutions 12.37%
Shares short (30 Apr 2024) 46.17k
Short ratio (30 Apr 2024) 40.26
Short % of float (30 Apr 2024) 40.96%
Short % of shares outstanding (30 Apr 2024) 40.94%
Shares short (prior month 28 Mar 2024) 41.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 317 May 2024

Financial highlights

Fiscal year

Fiscal year ends 30 Apr 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-10,376.75%

Management effectiveness

Return on assets (ttm)-52.73%
Return on equity (ttm)-152.61%

Income statement

Revenue (ttm)18.6k
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)653.80%
Gross profit (ttm)N/A
EBITDA -6M
Net income avi to common (ttm)-6.39M
Diluted EPS (ttm)-35.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.08M
Total cash per share (mrq)10.79
Total debt (mrq)1.06M
Total debt/equity (mrq)12.27%
Current ratio (mrq)5.09
Book value per share (mrq)13.57

Cash flow statement

Operating cash flow (ttm)-6.4M
Levered free cash flow (ttm)-4.89M